Wiadomości giełdowe
Najnowsze wiadomości finansowe · Zaktualizowano Maj 23, 2026
Dave Ramsey mówi żonie z ukrytym długiem w wysokości 30 000 $: „Dług jest symptomem, a nie problemem”.
Dave Ramsey Tells Wife With $30,000 in Hidden Debt: ‘The Debt Is the Symptom, Not the Problem’
The panel discussed the risks of hidden debt and low savings rates, with some arguing it could lead to increased …
Apple kończy 50 lat: od startupu z garażu do giganta za 3,73 biliona dolarów — oto ile warta byłaby dziś inwestycja 1000 dolarów w jego IPO
Apple Turns 50: From Garage Startup To $3.73 Trillion Giant—Here's How Much A $1,000 Investment At Its IPO Would Be Worth Today
The panelists generally agreed that Apple's current valuation and future growth prospects are uncertain, with significant risks and opportunities ahead.
Poprosiłem ChatGPT o wyjaśnienie Ethereum, jakbym miał 12 lat
I Asked ChatGPT To Explain Ethereum to Me Like I’m 12
The panel discussion on Ethereum's investment thesis highlights significant competition from other chains, regulatory risks, and the need for further …
Keir Starmalade, ktokolwiek? Czy marmolada naprawdę będzie musiała zostać przemianowana w Wielkiej Brytanii?
Keir Starmalade, anyone? Will marmalade really have to be rebranded in UK?
The panel generally agrees that the marmalade labeling change is a non-event for major UK food companies, with some long-term …
„Nie do końca Greggs”: twórcy na TikToku testują „zgentryfikowane” piekarnie w Londynie
‘Not quite Greggs’: TikTok creators put London’s ‘gentrified’ bakeries to the test
The panel's net takeaway is that while these premium-priced, artisanal bakeries benefit from TikTok-driven visibility, their long-term resilience and profitability …
Goldman Sachs podnosi swój cel cenowy dla PVH Corp. (PVH) do 93 USD z 83 USD
Goldman Sachs Raises its Price Target on PVH Corp. (PVH) to $93 from $83
The panelists had a mixed view on PVH's outlook, with some flagging risks like EMEA softness, reliance on margin expansion, …
Ascendis Pharma A/S (ASND) raportuje pozytywne dane z 52. tygodnia badania Phase 2 New InsiGHTS
Ascendis Pharma A/S (ASND) Reports Positive Week 52 Data from Phase 2 New InsiGHTS Trial
The panel discusses ASND's Week 52 Phase 2 data showing TransCon hGH's non-inferiority to daily somatropin, with YUVIWEL's EMA approval …
Wolfe Research rozpoczyna analizę BeOne Medicines AG (ONC) z ratingiem Outperform
Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating
The panel is neutral on BeOne Medicines (ONC), with concerns about Brukinsa's long-term margins due to generic competition and uncertainty …
Mizuho obniża swój docelowy cenowy na Autolus Therapeutics plc (AUTL) z 12 USD do 10 USD
Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12
The panelists debated AUTL's outlook, with some highlighting its strong Q4 results and potential for 2026 inflection, while others raised …
Galapagos NV (GLPG) zawiera umowę z Gilead w sprawie aktywów Ouro Medicines
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
GLPG's partnership with Gilead on gamgertamig provides a pipeline extension and potential near-to-mid-term catalyst, but the deal's true value lies …
RBC Capital obniża cenę docelową dla Bicycle Therapeutics plc (BCYC) do 7 USD z 11 USD
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
BCYC's one-time revenue from terminated partnerships masks a pivot away from zelenectide due to regulatory feedback, reducing near-term commercialization visibility. …
Najlepsze ETF-y dla ceny ropy na poziomie 100 USD, które warto kupić teraz
The Best ETFs For $100 Oil To Buy Right Now
The panel consensus is that while $105 WTI is driven by geopolitical risks, it may not be sustained due to …